Tirzepatide is a dual-action medication that targets both GLP-1 and GIP receptors, which is why clinical trials have shown it producing greater average weight loss than semaglutide alone
Due to possible side effects like nausea, vomiting, diarrhea and dizziness or other more serious reactions
Professional laboratories provide you with various tests
Liraglutide has the most robust evidence base specifically in NASH, given the LEAN trial results
Symptoms worth reaching out about: Stomach pain that's intense or doesn't go away, particularly if it spreads to your back Vomiting that doesn't ease up, or signs that you're getting dehydrated Pain on the upper right side of your abdomen Lightheadedness, shakiness, or confusion, especially if you also take insulin or another medication for blood sugar Swelling, hives, or any unusual reaction following a dose New neck symptoms like swelling, hoarseness, or trouble swallowing If something feels off or unfamiliar, send us a message
Packaging Each product is supplied in a laboratory-grade sealed glass vial , designed to protect the solution from contamination and environmental exposure during storage and transportation